Vontobel Holding
WST icon

Vontobel Holding’s West Pharmaceutical WST Stock Holding History

Vontobel Holding’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$716K Sell
1,932
-322
-14% -$114K ﹤0.01% 942
2026
Q2 		$809K Sell
2,254
-20
-0.9% -$6.12K ﹤0.01% 885
2026
Q1 		$570K Buy
2,274
+314
+16% +$78.1K ﹤0.01% 800
2025
Q4 		$539K Sell
1,960
-121
-6% -$33.1K ﹤0.01% 962
2025
Q3 		$546K Sell
2,081
-599
-22% -$146K ﹤0.01% 918
2025
Q2 		$586K Buy
2,680
+17
+0.6% +$3.63K ﹤0.01% 850
2025
Q1 		$596K Sell
2,663
-206
-7% -$56.8K ﹤0.01% 728
2024
Q4 		$940K Buy
2,869
+175
+6% +$55.1K ﹤0.01% 615
2024
Q3 		$809K Buy
2,694
+316
+13% +$96.8K ﹤0.01% 646
2024
Q2 		$783K Sell
2,378
-224
-9% -$79.2K ﹤0.01% 636
2024
Q1 		$1.03M Buy
2,602
+127
+5% +$47K 0.01% 578
2023
Q4 		$871K Sell
2,475
-148
-6% -$52.4K 0.01% 632
2023
Q3 		$984K Sell
2,623
-350
-12% -$135K 0.01% 587
2023
Q2 		$1.14M Sell
2,973
-1,474
-33% -$527K 0.01% 565
2023
Q1 		$1.54M Sell
4,447
-1,658
-27% -$484K 0.01% 479
2022
Q4 		$1.41M Buy
6,105
+698
+13% +$165K 0.01% 493
2022
Q3 		$1.33M Sell
5,407
-13
-0.2% -$3.96K 0.02% 484
2022
Q2 		$1.62M Sell
5,420
-1,155
-18% -$376K 0.02% 426
2022
Q1 		$2.75M Sell
6,575
-709
-10% -$278K 0.02% 370
2021
Q4 		$3.43M Buy
7,284
+379
+5% +$163K 0.03% 331
2021
Q3 		$2.93M Sell
6,905
-674
-9% -$284K 0.03% 371
2021
Q2 		$2.73M Buy
7,579
+798
+12% +$264K 0.02% 384
2021
Q1 		$1.91M Sell
6,781
-191
-3% -$54.7K 0.01% 409
2020
Q4 		$2.05M Buy
+6,972
New +$1.96M 0.01% 401

Other funds holding WST

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Border to Coast Pensions Partnership
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Vontobel Holding's WST Position: Q3 2026 in Review

Vontobel Holding reduced its West Pharmaceutical (WST) stake by 14% in Q3 2026, selling an estimated $114K and leaving 1,932 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #942.

Vontobel Holding first reported a position in WST in Q4 2020 and has held it in 24 quarters since. The position peaked at $3.43M in Q4 2021. 430 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Vontobel Holding held 1,932 shares of West Pharmaceutical worth $716K as of Q3 2026.
  • Vontobel Holding sold 322 West Pharmaceutical shares in Q3 2026, an estimated $114K.
  • West Pharmaceutical made up ﹤0.01% of Vontobel Holding's portfolio in Q3 2026, its #942 holding.
  • Vontobel Holding first reported a position in West Pharmaceutical in Q4 2020 and has held it in 24 quarters since.
  • Vontobel Holding's West Pharmaceutical position peaked at $3.43M in Q4 2021.
  • 430 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Vontobel Holding's 13F filing for Q3 2026, filed 16 Oct 2026.